Bayer aborts late-stage trial of anticoagulant drug due to inefficacy
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian.
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian.
HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda
HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5
HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of
HQ Team November 18, 2023: A plan to create a safe zone at Gaza’s Al-Mawasi is a “recipe for disaster” and the WHO
HQ Team November 17, 2023: Levofloxacin, an antibiotic, has emerged as a potent weapon against drug-resistant tuberculosis, offering a cost-effective solution with profound
HQ Team November 17, 2023: The number of countries battling measles outbreaks has increased to 37 in 2022 from 22 in 2021, marking
HQ team November 17, 2023: A recent study suggests that delaying the clamping of the umbilical cord for premature babies may decrease the
HQ Team November 16, 2023: One in four older people experience social isolation, and one in six adolescents is socially isolated and lonely,
HQ Team November 16, 2023: The USFDA has approved a first test for chlamydia and gonorrhea that will allow people to collect samples